134 related articles for article (PubMed ID: 5974487)
1. [Determination of the effective dose for the in-vitro destruction of Ehrlich mice ascites carcinoma cells by nitrogen mustard oxide].
von Ardenne M; Reitnauer PG
Acta Biol Med Ger; 1966; 16(1):43-53. PubMed ID: 5974487
[No Abstract] [Full Text] [Related]
2. [Correlations between chemical structure and biological activity of azomethines with nitrogen-mustard-groups on Ehrlich ascites tumor in albino mice. 3. Activation of N-mustard-azomethines by cells of Ehrlich ascites carcinoma].
Schulze W; Horn G
Arzneimittelforschung; 1970 Mar; 20(3):329-35. PubMed ID: 5467506
[No Abstract] [Full Text] [Related]
3. A study on the mechanism of resistance to nitrogen mustard (HN2) in Ehrlich ascites tumor cells: comparison of uptake of HN2-14-C into sensitive and resistant cells.
Wolpert MK; Ruddon RW
Cancer Res; 1969 Apr; 29(4):873-9. PubMed ID: 5775714
[No Abstract] [Full Text] [Related]
4. Studies on the effect of homo-aza-steroidal ester of p-bis (2-chloroethyl) amino phenyl acetic acid in Ehrlich ascites tumor cells.
Papageorgiou A; Koliais SI; Antonoglou O; Catsoulacos P; Boutis L
Methods Find Exp Clin Pharmacol; 1984 Jan; 6(1):5-9. PubMed ID: 6717170
[TBL] [Abstract][Full Text] [Related]
5. [Comparative studies of the cytostatic effect of a new N-Lost derivative "IMET 3393" and Endoxan in 3 experimental mice tumors (Ehrlich ascites carcinoma, sarcoma 180 solid, leukemia LAJ I)].
Schnabel R; Jungstand W; Gutsche W; Grimm H; Fritsch S
Acta Biol Med Ger; 1967; 19(4):543-58. PubMed ID: 5596676
[No Abstract] [Full Text] [Related]
6. [Relationships between chemical structure and biological activity in azomethines with nitrogen mustard groups on Ehrlich ascites tumor of the white mouse. 2. Azomethine without N-mustard groups as comparative substances and N-mustard azomethine with additional substitutions in the phenyl group].
Schulze W; Gutsche W; Jungstand W
Arzneimittelforschung; 1967 May; 17(5):605-7. PubMed ID: 5631589
[No Abstract] [Full Text] [Related]
7. Differences in the in vivo alkylation and cross-linking of nitrogen mustard-sensitive and -resistant lines of Lettré-Ehrlich asites tumors.
Chun EH; Gonzales L; Lewis FS; Jones J; Rutman RJ
Cancer Res; 1969 Jun; 29(6):1184-94. PubMed ID: 5797106
[No Abstract] [Full Text] [Related]
8. Evaluation of phthalmustine, a new anticancer compound. II. Tumor inhibitory effect in murine Ehrlich ascites carcinoma and sarcoma-180.
Bhattacharya S; Ghosh M; Sadhu U; Dutta S; Sanyal U
Neoplasma; 1996; 43(3):209-13. PubMed ID: 8841510
[TBL] [Abstract][Full Text] [Related]
9. The effect of nitrogen mustards on glutamate metabolism in rat liver mitochondria and Ehrlich ascites cells.
Raczyńska-Bojanowska K; Gasiorowska I
Acta Biochim Pol; 1966; 13(2):113-20. PubMed ID: 5914476
[No Abstract] [Full Text] [Related]
10. The synergic action of the bovine growth hormone with some cytostatic drugs in the experimental therapy of Ehrlich and NK-Ly ascites tumors in mice.
Baranowicz JW
Neoplasma; 1973; 20(1):47-50. PubMed ID: 4121992
[No Abstract] [Full Text] [Related]
11. [On the growth-inhibiting effect of some new N mustard compounds on Ehrlich ascites carcinoma, Nemeth-Kellner lymphoma (ascites form) and solid sarcoma 180].
Jugstand W; Gutsche W; Wiangke H
Arzneimittelforschung; 1966 May; 16(5):634-7. PubMed ID: 6014431
[No Abstract] [Full Text] [Related]
12. [Correlations between the chemical structure of Mannich bases with and without nitrogen mustard groups and their cytostatic effect on Ehrlich ascites carcinoma in albino mice].
Werner W; Jungstand W; Gutsche W
Arzneimittelforschung; 1970 Feb; 20(2):246-9. PubMed ID: 5467470
[No Abstract] [Full Text] [Related]
13. Permeation of cyclophosphamide (NSC-26271) metabolites into tumor cells.
Draeger U; Hohorst HJ
Cancer Treat Rep; 1976 Apr; 60(4):423-7. PubMed ID: 1277217
[TBL] [Abstract][Full Text] [Related]
14. The effect of high pressure oxygen and nitrogen mustard on the Ehrlich ascites tumor.
Cohen A; Weg N; Fanning GL; Collea JV; Russo MA; Rogers LS; DeCosse JJ
Arch Surg; 1966 Oct; 93(4):638-42. PubMed ID: 5922037
[No Abstract] [Full Text] [Related]
15. [Metabolism of nitrogen in Ehrlich ascites tumor cells: role of glutamine and ammonium].
Carrascosa JM; Martínez P; Núñez de Castro I
Rev Esp Oncol; 1983; 30(4):533-7. PubMed ID: 6599917
[TBL] [Abstract][Full Text] [Related]
16. [Daily periodic variations in the potency of the cancerostatic effect of nitrogen mustard oxide in Ehrlich ascites carcinoma in mice].
POHLE K; MATTHIES E; MENG K
Z Krebsforsch; 1961; 64():215-18. PubMed ID: 13736566
[No Abstract] [Full Text] [Related]
17. Nitrogen mustard interference with potassium transport systems in Ehrlich ascites tumor cells.
Doppler W; Hofmann J; Oberhuber H; Maly K; Grunicke H
J Cancer Res Clin Oncol; 1985; 110(1):35-41. PubMed ID: 4019567
[TBL] [Abstract][Full Text] [Related]
18. [The time dependent, electronically measured change in volume frequency distribution of Ehrlich ascites tumor cells after treatment with alkylating cytostatics in vivo].
Gutsche W
Arzneimittelforschung; 1971 Apr; 21(4):444-6. PubMed ID: 5108137
[No Abstract] [Full Text] [Related]
19. Increase in dry mass of Ehrlich ascites tumor cells after treatment with nitrogen mustard.
LEE H; RICHARDS V; FURST A
Cancer Res; 1961 Oct; 21():1108-12. PubMed ID: 14463490
[No Abstract] [Full Text] [Related]
20. [Antiblastic effect of various chemotherapeutic preparations on the cells of the Ehrlich ascites tumor].
Papoian SA; Kumkumadzhian VA
Vopr Onkol; 1966 Apr; 12(4):56-61. PubMed ID: 6001002
[No Abstract] [Full Text] [Related]
[Next] [New Search]
